SCHEMBL348014

SCHEMBL348014

ClCCI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methylsulfanylmethane SCHEMBL4733211 0.82
SCHEMBL114898 0.75
SCHEMBL35847 0.72
SCHEMBL874852 0.71
SCHEMBL5613164 0.69 TSHR (0.44)
SCHEMBL10983419 0.69 TSHR (0.44)
SCHEMBL10983764 0.69 TSHR (0.44)
SCHEMBL10977458 0.69 TSHR (0.44)
SCHEMBL10978907 0.69 TSHR (0.44)
SCHEMBL10983704 0.69 TSHR (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 640 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250069948-A1 DEPOSITION OF METALS IN RECESSED FEATURES WITH THE USE OF HALOGEN-CONTAINING DEPOSITION INHIBITORS LAM RESEARCH CORPORATION (US) 2025-02-27 US claimed
EP-4448831-A1 DEPOSITION OF METALS IN RECESSED FEATURES WITH THE USE OF HALOGEN-CONTAINING DEPOSITION INHIBITORS Lam Research Corporation (US) 2024-10-23 EP claimed
CN-118434908-A Metal deposition in recessed features using halogen-containing deposition inhibitors 朗姆研究公司 2024-08-02 CN claimed
US-20240174646-A1 METHYLLACTAM RING COMPOUND AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC (JP) 2024-05-30 US claimed
EP-4267591-A2 ORGANOMETALLIC COMPOUNDS Umicore AG & Co. KG (DE) 2023-11-01 EP claimed
CN-116802187-A Organometallic compounds 优米科尔股份公司及两合公司 2023-09-22 CN claimed
WO-2023114640-A1 DEPOSITION OF METALS IN RECESSED FEATURES WITH THE USE OF HALOGEN-CONTAINING DEPOSITION INHIBITORS LAM RESEARCH CORPORATION (US) 2023-06-22 WO claimed
WO-2022136049-A2 ORGANOMETALLIC COMPOUNDS UMICORE AG & CO. KG (DE) 2022-06-30 WO claimed
US-20220185810-A1 Novel Process for the Preparation of Filgotinib and Intermediates Thereof UNICHEM LABORATORIES LIMITED (IN) 2022-06-16 US claimed
CN-112479937-B Preparation method of 2- [ [ tri (hydroxymethyl) methyl ] amino ] ethanesulfonic acid 苏州亚科科技股份有限公司 2022-04-08 CN claimed
CN-101195578-B Synthesis method of 1- (haloalkoxy) -2-alkoxy-5-nitrobenzene compounds SHANGHAI RUIZHI CHEMICAL STUDY CO LTD 2012-04-25 CN claimed
CN-101195578-A Method for synthesizing 1-(halogen alkoxyl)-2-alkoxyl-5-nitrobenzene compounds SHANGHAI RUIZHI CHEMICAL STUDY (CN) 2008-06-11 CN claimed
EP-1461342-B1 STREPTOGRAMIN DERIVATIVES, PREPARATION THEREOF AND COMPOSITIONS CONTAINING SAME AVENTIS PHARMA SA (FR) 2007-03-07 EP claimed
US-6878820-B2 Streptogramin derivatives, their preparation and compositions containing them AVENTIS PHARMA S. A. (FR) 2005-04-12 US claimed
EP-1461342-A1 STREPTOGRAMIN DERIVATIVES, PREPARATION THEREOF AND COMPOSITIONS CONTAINING SAME Aventis Pharma S.A. (FR) 2004-09-29 EP claimed
US-20030162962-A1 Streptogramin derivatives, their preparation and compositions containing them AVENTIS PHARMA S.A. (FR) 2003-08-28 US claimed
WO-2003055891-A1 STREPTOGRAMIN DERIVATIVES, PREPARATION THEREOF AND COMPOSITIONS CONTAINING SAME AVENTIS PHARMA S.A. (FR) 2003-07-10 WO claimed
EP-0213337-B1 4-CYANOPIPERIDINE DERIVATIVES, PREPARATION AND USE THEREOF Eisai Co., Ltd. (JP) 1991-05-15 EP claimed
EP-0213337-A1 4-cyanopiperidine derivatives, preparation and use thereof Eisai Co., Ltd. (JP) 1987-03-11 EP claimed
US-4026911-A CYANATION, HYDROLYSIS MILES LABORATORIES, INC. (US) 1977-05-31 US claimed